The impact of teriparatide adherence and persistence on fracture outcomes

A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence

(2011) Susan Ross et al.   VALUE IN HEALTH

Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance

(2010) S. A. Foster et al.   OSTEOPOROSIS INTERNATIONAL

Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS)

(2010) A. Fahrleitner-Pammer et al.   OSTEOPOROSIS INTERNATIONAL

Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe

(2009) Ethel S. Siris et al.   AMERICAN JOURNAL OF MEDICINE

Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS)

(2009) Bente L. Langdahl et al.   CALCIFIED TISSUE INTERNATIONAL

The Role of Medical Liability Reform in Federal Health Care Reform

(2009) Michelle M. Mello et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fracture Outcomes Related to Persistence and Compliance With Oral Bisphosphonates

(2008) Arlene M Gallagher et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis

(2008) R. Lindsay et al.   OSTEOPOROSIS INTERNATIONAL